These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 22544933)
21. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Liu B; Wu X; Liu B; Wang C; Liu Y; Zhou Q; Xu K Biochim Biophys Acta; 2012 Nov; 1822(11):1692-704. PubMed ID: 22885155 [TBL] [Abstract][Full Text] [Related]
22. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210. Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559 [TBL] [Abstract][Full Text] [Related]
23. Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2. Hu X; Li B; Li X; Zhao X; Wan L; Lin G; Yu M; Wang J; Jiang X; Feng W; Qin Z; Yin B; Li Z J Immunol; 2014 Feb; 192(3):1320-31. PubMed ID: 24379122 [TBL] [Abstract][Full Text] [Related]
24. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231 [TBL] [Abstract][Full Text] [Related]
26. Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer. D'Amico L; Mahajan S; Capietto AH; Yang Z; Zamani A; Ricci B; Bumpass DB; Meyer M; Su X; Wang-Gillam A; Weilbaecher K; Stewart SA; DeNardo DG; Faccio R J Exp Med; 2016 May; 213(5):827-40. PubMed ID: 27045006 [TBL] [Abstract][Full Text] [Related]
27. The CUL4B/AKT/β-Catenin Axis Restricts the Accumulation of Myeloid-Derived Suppressor Cells to Prohibit the Establishment of a Tumor-Permissive Microenvironment. Qian Y; Yuan J; Hu H; Yang Q; Li J; Zhang S; Jiang B; Shao C; Gong Y Cancer Res; 2015 Dec; 75(23):5070-83. PubMed ID: 26450912 [TBL] [Abstract][Full Text] [Related]
28. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. Bianchi G; Vuerich M; Pellegatti P; Marimpietri D; Emionite L; Marigo I; Bronte V; Di Virgilio F; Pistoia V; Raffaghello L Cell Death Dis; 2014 Mar; 5(3):e1135. PubMed ID: 24651438 [TBL] [Abstract][Full Text] [Related]
29. miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Guo B; Liu L; Yao J; Ma R; Chang D; Li Z; Song T; Huang C Mol Cancer Res; 2014 Mar; 12(3):313-21. PubMed ID: 24375644 [TBL] [Abstract][Full Text] [Related]
30. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model. Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503 [TBL] [Abstract][Full Text] [Related]
31. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells. Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153 [TBL] [Abstract][Full Text] [Related]
32. Suppression of Mll1-Complex by Stat3/Cebpβ-Induced miR-21a/21b/181b Maintains the Accumulation, Homeostasis, and Immunosuppressive Function of Polymorphonuclear Myeloid-Derived Suppressor Cells. Zhang Z; Huang X; Wang E; Huang Y; Yang R J Immunol; 2020 Jun; 204(12):3400-3415. PubMed ID: 32358019 [TBL] [Abstract][Full Text] [Related]
33. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Palumbo T; Faucz FR; Azevedo M; Xekouki P; Iliopoulos D; Stratakis CA Oncogene; 2013 Mar; 32(13):1651-9. PubMed ID: 22614013 [TBL] [Abstract][Full Text] [Related]
34. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas. Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836 [TBL] [Abstract][Full Text] [Related]
35. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412 [TBL] [Abstract][Full Text] [Related]
36. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling. Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-200c inhibits apoptosis in pituitary adenoma cells by targeting the PTEN/Akt signaling pathway. Liao C; Chen W; Fan X; Jiang X; Qiu L; Chen C; Zhu Y; Wang H Oncol Res; 2013; 21(3):129-36. PubMed ID: 24512727 [TBL] [Abstract][Full Text] [Related]
38. Myeloid-derived suppressor cells accumulate among myeloid cells contributing to tumor growth in matrix metalloproteinase 12 knockout mice. Li J; Zhang X; Liu Q; Yang M; Zhou Z; Ye Y; Zhou Z; He X; Wang L Cell Immunol; 2018 May; 327():1-12. PubMed ID: 29555056 [TBL] [Abstract][Full Text] [Related]
39. MiR-486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro. Jiang J; Gao Q; Gong Y; Huang L; Lin H; Zhou X; Liang X; Guo W Cancer Med; 2018 Sep; 7(9):4627-4638. PubMed ID: 30073773 [TBL] [Abstract][Full Text] [Related]
40. Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. Li LM; Hou DX; Guo YL; Yang JW; Liu Y; Zhang CY; Zen K J Immunol; 2011 Feb; 186(4):2552-60. PubMed ID: 21228352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]